Page last updated: 2024-12-08

Canin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID442175
CHEBI ID3356

Synonyms (11)

Synonym
canin
C09354
24959-84-0
chebi:3356 ,
4h-bisoxireno(1,8a:2,3)azuleno(4,5-b)furan-2(3h)-one, octahydro-6-hydroxy-6,8a-dimethyl-3-methylene-, (3as-(3aalpha,6alpha,6as*,7abeta,7bbeta,8abeta,8balpha,8cbeta))-
octahydro-6-hydroxy-6,8a-dimethyl-3-methylene-4h-bisoxireno(1,8a:2,3)azuleno(4,5-b)furan-2(3h)-one (3as-(3aalpha,6alpha,6as*,7abeta,7bbeta,8abeta,8balpha,8cbeta))-
canin (chrysartemin a)
Q27106041
6-hydroxy-6,8a-dimethyl-3-methylideneoctahydro-4h-bisoxireno[2,3:1,8a]azuleno[4,5-b]furan-2(3h)-one
DTXSID70947832
(1r,2r,5s,9s,10s,11s,13r,14s)-2-hydroxy-2,11-dimethyl-6-methylidene-8,12,15-trioxapentacyclo[8.5.0.01,14.05,9.011,13]pentadecan-7-one
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
sesquiterpene lactoneAny member of a diverse class of complex, multicyclic phytochemicals showing a variety of skeleton arrangements and bioactivities, and having in common a sesquiterpenoid structure including a lactone ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID1594833Immunosuppressant activity in human T lymphocytes assessed as inhibition of anti-human CD3 and anti-human CD28 monoclonal antibody-induced T lymphocyte proliferation incubated for 72 hrs by FACS analysis2019Journal of natural products, 06-28, Volume: 82, Issue:6
Sesquiterpene Lactones from Artemisia argyi: Absolute Configuration and Immunosuppressant Activity.
AID1875649Inhibition of PI3K/AKT signalling pathway in human MM121224 cells stably expressing H2B-mTurquoise, ERK-KTR-mScarlet and FoxO3a-KTR-mNeonGreen fluorophore assessed as AKT activity by high-content screening microscopic analysis
AID336310Antimigraine activity in bovine citreated platelet assessed as inhibition of [14C]serotonin release after 6 mins by scintillation counting1992Journal of natural products, Aug, Volume: 55, Issue:8
A bioassay for inhibition of serotonin release from bovine platelets.
AID1875650Inhibition of MAPK/ERK signalling pathway in human MM121224 cells stably expressing H2B-mTurquoise, ERK-KTR-mScarlet and FoxO3a-KTR-mNeonGreen fluorophore assessed as effect on EKR-KTR activity by high-content screening microscopic analysis
AID320961Inhibition of serotonin release in bovine platelets2008Journal of medicinal chemistry, Mar-13, Volume: 51, Issue:5
Neural networks as valuable tools to differentiate between sesquiterpene lactones' inhibitory activity on serotonin release and on NF-kappaB.
AID355723Cytotoxicity against human HCT116 cells by MTT assay2003Journal of natural products, Apr, Volume: 66, Issue:4
Sesquiterpenoids from Artemisia gilvescens and an anti-MRSA compound.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 138.87

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index138.87 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.55 (4.65)
Search Engine Demand Index316.77 (26.88)
Search Engine Supply Index2.52 (0.95)

This Compound (138.87)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]